Pressure BioSciences Engages IssuWorks in Strategic Advisory Role

SOUTH EASTON, Mass., June 26, 2014 /PRNewswire/  Pressure BioSciences, Inc. (OTCQB: PBIO) ( PBI or the Company ) today announced the engagement of IssuWorks to provide strategic advisory services to the Company s board of directors and management team.  IssuWorks is the first conflict-free, company-aligned investment bank using technology and services to dramatically improve investor targeting, securities marketing, and distribution in public and private markets. Pressure BioSciences has retained IssuWorks and their management team to review strategic and financing alternatives, including the possible spin-off of vertical market applications into new, stand alone businesses. IssuWorks is the brainchild of noted Wall Street executives, including David Weild and Ed Kim, who are recognized in the U.S. and abroad for their work on how stock market structure can impact a company s stock price and their access to capital.   David has been called The father of the JOBS Act for work w
http://bit.ly/1lhHCd2